Preliminary phase II data for eganelisib plus nivolumab in advanced urothelial carcinoma Feb. 16, 2021
FDA approves Cosela for myeloprotection in patients with extensive-stage SCLC receiving chemotherapy Feb. 15, 2021
Artios initiates phase I/IIa trial of ATR inhibitor ART-0380 in advanced or metastatic solid tumors Feb. 11, 2021
New phase III study evaluates AZD-9833 with palbociclib in ER-positive HER2-negative breast cancer Feb. 11, 2021
RSS